A resident of Northern Arizona recently died after being infected with the pneumonic plague, the first death in the US since 2007.

Digital inhalers can detect significant changes in physiologic and inhaler use metrics in the 14 days before COPD exacerbations.

The FDA sent letters instructing companies to stop their marketing of concentrated 7-OH, a compound found in kratom.

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

Lung function trajectories for FEV1 and FVC increase rapidly in children until the mid-teens, then peak at age 20 in females and 23 years in males.

Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

The CDC confirmed a nationwide uptick in COVID-19 cases, with increases seen in 25 states, suggesting a summer spike.